The biopharma-catalyst-mcp is a sophisticated forensic biopharma research tool designed to enhance analytical workflows for biopharma analysts. This server-based platform utilizes a unique aggregation of ten essential tools that systematically extract and cross-reference critical data from six reputable sources, including ClinicalTrials.gov, PubMed, SEC EDGAR, openFDA, and Yahoo Finance, to deliver precise and actionable insights in a matter of seconds.

Key Features

• Headline Tool: audit_catalyst
  The primary utility of this project, audit_catalyst, processes any sponsor/drug combination to return a single deterministic verdict — either CLEAN, BEAR_SIGNAL, or BLACK_FLAG. It enables users to verify the integrity of their biopharma thesis rapidly:

  audit_catalyst(ticker="MRK", drug="Keytruda", sponsor="Merck")
  → Verdict: CLEAN (MED)
  

This verdict signifies a comprehensive cross-examination of signals, streamlining what could typically require hours of extensive research into roughly 30 seconds.

• Full Forensic Workflow
  The server features an aggregator that implements a complete forensic workflow with a singular tool call to evaluate the integrity of drug-catalyst propositions, offering clarity on market signals and internal analytics.

Verdict Scale Explained

The audit_catalyst tool provides verdicts that represent the degree of confidence in a drug's potential based on its clinical and market data:

• CLEAN: Verifies thesis integrity; no major concerns identified.
• FLAG: Identifies data ambiguities; suggest further investigation.
• BEAR_SIGNAL: Major concerns raised that could jeopardize the investment rationale.
• BLACK_FLAG: Severe warning, indicating critical risk factors.

Advantages for Analysts

The biopharma-catalyst-mcp drastically reduces the time spent researching and verifying biopharma investments. For instance, instead of poring over multiple databases and documentation, a streamlined query can consolidate numerous evaluations, surfacing all necessary details succinctly.

Analysts can dive directly into critical analysis with flexible inputs. By querying with drug names rather than corporate tickers, analysts can draw more specific insights from clinical pipelines and understand the underlying value of potential investments with greater clarity.

Integration and Usage Examples

Designed to function seamlessly in a range of environments, this tool is easily configurable and can be run via command-line interface (CLI) for headless operations, providing structured output suitable for both live analysis and batch processing. Examples of its capabilities include:

node build/cli.js <TICKER> "<DRUG_NAME>" "<SPONSOR_NAME>"

Various configurations allow users to tailor their research processes to specific needs, adapting the data sources for comprehensive analysis.

Summary

The biopharma-catalyst-mcp stands out as a pioneering tool in biopharmaceutical analysis, designed to streamline the research process, provide actionable insights quickly, and support informed investment decisions. By leveraging a powerful combination of resources, this project enhances operational efficiency for retail biopharma analysts and fosters a deeper understanding of the catalytic factors influencing drug approvals and market performance.